Skip to content
2000
image of DSPE: An End-to-End Drug Synergy Combination Prediction Algorithm for Echinococcosis

Abstract

Background

Echinococcosis, a parasitic disease caused by the larvae of the Echinococcus parasite, poses a serious threat to human health. Medication is an indispensable means of treatment for Echinococcosis; however, due to the less satisfactory efficacy of single drugs, identifying effective drug combinations for the treatment of Echinococcosis is essential. Yet, current predictive models for drug synergy in Echinococcosis face accuracy challenges due to data scarcity, method limitations, and insufficient feature representation.

Objective

This work aims to design an end-to-end method to predict drug synergistic combinations, which enables efficient and accurate identification of drug combinations against Echinococcosis.

Methods

In this work, an end-to-end method, named DSPE, is proposed for predicting anti-Echinococcosis drug synergistic combinations. In DSPE, a dataset of Echinococcosis drug synergistic combinations is constructed by retrieving and extracting information from related scientific articles. Further, DSPE employs a residual graph attention network to deeply analyze drug characteristics and their interactions, thereby enhancing the performance of deep learning models. It also explores the protein-protein interaction network related to Echinococcosis, using node2vec combined with an attention mechanism to efficiently encode disease features. Finally, it predicts the synergy of drug combinations based on the Bliss score by integrating drug combinations and disease features.

Results

Experimental evidence shows that DSPE outperforms five state-of-the-art algorithms in predicting drug combination effects by leveraging disease-target information and single-agents for the treatment.

Conclusion

DSPE improves prediction accuracy and addresses the issue of data scarcity for new diseases, offering new insights and methods for the development of treatment plans for parasitic diseases in the future.

Loading

Article metrics loading...

/content/journals/cbio/10.2174/0115748936325300241009051347
2025-01-07
2025-06-21
Loading full text...

Full text loading...

References

  1. Lupia T. Corcione S. Guerrera F. Costardi L. Ruffini E. Pinna S.M. Rosa F.G.D. Pulmonary Echinococcosis or Lung Hydatidosis: A Narrative Review. Surg. Infect. (Larchmt.) 2021 22 5 485 495 10.1089/sur.2020.197 33297827
    [Google Scholar]
  2. Rosa F.G.D. Alveolar Echinococcosis in immunocompromised hosts. Clinical microbiology and infection. European Soc. Clin. Microbiol. Infect. Dis. 2023 2023 29
    [Google Scholar]
  3. Weber T.F. Junghanss T. Stojković M. Pulmonary cystic echinococcosis. Curr. Opin. Infect. Dis. 2023 36 5 318 325 10.1097/QCO.0000000000000962 37578473
    [Google Scholar]
  4. Habibi B. Gholami S. Bagheri A. Fakhar M. Moradi A. Khazeei Tabari M.A. Cystic echinococcosis microRNAs as potential noninvasive biomarkers: Current insights and upcoming perspective. Expert Rev. Mol. Diagn. 2023 23 10 885 894 10.1080/14737159.2023.2246367 37553726
    [Google Scholar]
  5. Torkamannia A. Omidi Y. Ferdousi R. A review of machine learning approaches for drug synergy prediction in cancer. Brief. Bioinform. 2022 23 3 bbac075 10.1093/bib/bbac075 35323854
    [Google Scholar]
  6. Chai J.Y. Jung B.K. Hong S.J. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: An update. Korean J. Parasitol. 2021 59 3 189 225 10.3347/kjp.2021.59.3.189 34218593
    [Google Scholar]
  7. Wang C.C. Zhao Y. Chen X. Drug-pathway association prediction: From experimental results to computational models. Brief. Bioinform. 2021 22 3 bbaa061 10.1093/bib/bbaa061 32393976
    [Google Scholar]
  8. Zheng W. Sun W. Simeonov A. Drug repurposing screens and synergistic drug‐combinations for infectious diseases. Br. J. Pharmacol. 2018 175 2 181 191 10.1111/bph.13895 28685814
    [Google Scholar]
  9. Sałat R. Sałat K. The application of support vector regression for prediction of the antiallodynic effect of drug combinations in the mouse model of streptozocin-induced diabetic neuropathy. Comput. Methods Programs Biomed. 2013 111 2 330 337 10.1016/j.cmpb.2013.04.018 23693136
    [Google Scholar]
  10. Kim Y. Zheng S. Tang J. Jim Zheng W. Li Z. Jiang X. Anticancer drug synergy prediction in understudied tissues using transfer learning. J. Am. Med. Inform. Assoc. 2021 28 1 42 51 10.1093/jamia/ocaa212 33040150
    [Google Scholar]
  11. Qi Y. Random Forest for Bioinformatics. 2012 Available From: https://www.cs.cmu.edu/~qyj/papersA08/11-rfbook.pdf
  12. Liu H. Zhang W. Nie L. Ding X. Luo J. Zou L. Predicting effective drug combinations using gradient tree boosting based on features extracted from drug-protein heterogeneous network. BMC Bioinformatics 2019 20 1 645 10.1186/s12859‑019‑3288‑1 31818267
    [Google Scholar]
  13. Shi J.Y. Li J.X. Gao K. Lei P. Yiu S.M. Predicting combinative drug pairs towards realistic screening via integrating heterogeneous features. BMC Bioinformatics 2017 18 S12 Suppl. 12 409 10.1186/s12859‑017‑1818‑2 29072137
    [Google Scholar]
  14. Lin W. Wu L. Zhang Y. Wen Y. Yan B. Dai C. Liu K. He S. Bo X. An enhanced cascade-based deep forest model for drug combination prediction. Brief. Bioinform. 2022 23 2 bbab562 10.1093/bib/bbab562 35062018
    [Google Scholar]
  15. Lin X. Dai L. Zhou Y. Yu Z.G. Zhang W. Shi J.Y. Cao D.S. Zeng L. Chen H. Song B. Yu P.S. Zeng X. Comprehensive evaluation of deep and graph learning on drug–drug interactions prediction. Brief. Bioinform. 2023 24 4 bbad235 10.1093/bib/bbad235 37401373
    [Google Scholar]
  16. Preuer K. Lewis R.P.I. Hochreiter S. Bender A. Bulusu K.C. Klambauer G. DeepSynergy: Predicting anti-cancer drug synergy with Deep Learning. Bioinformatics 2018 34 9 1538 1546 10.1093/bioinformatics/btx806 29253077
    [Google Scholar]
  17. Wang J. Liu X. Shen S. Deng L. Liu H. DeepDDS: Deep graph neural network with attention mechanism to predict synergistic drug combinations. Brief. Bioinform. 2022 23 1 bbab390 10.1093/bib/bbab390 34571537
    [Google Scholar]
  18. Yang J. Xu Z. Wu W.K.K. Chu Q. Zhang Q. GraphSynergy: A network-inspired deep learning model for anticancer drug combination prediction. J. Am. Med. Inform. Assoc. 2021 28 11 2336 2345 10.1093/jamia/ocab162 34472609
    [Google Scholar]
  19. Li H. Zou L. Kowah J.A.H. He D. Wang L. Yuan M. Liu X. Predicting drug synergy and discovering new drug combinations based on a graph autoencoder and convolutional neural network. Interdiscip. Sci. 2023 15 2 316 330 10.1007/s12539‑023‑00558‑y 36943614
    [Google Scholar]
  20. Wang T. Wang R. Wei L. AttenSyn: An attention-based deep graph neural network for anticancer synergistic drug combination prediction. J. Chem. Inf. Model. 2023 37565997
    [Google Scholar]
  21. Xu M. Zhao X. Wang J. Feng W. Wen N. Wang C. Wang J. Liu Y. Zhao L. DFFNDDS: Prediction of synergistic drug combinations with dual feature fusion networks. J. Cheminform. 2023 15 1 33 10.1186/s13321‑023‑00690‑3 36927504
    [Google Scholar]
  22. Veličković P Cucurull G Casanova A Graph attention networks. arXiv:1710.10903 2018
    [Google Scholar]
  23. Grover A Leskovec J. node2vec: Scalable feature learning for networks. arXiv:1607.00653 2016
    [Google Scholar]
  24. Pandey M. Radaeva M. Mslati H. Garland O. Fernandez M. Ester M. Cherkasov A. Ligand binding prediction using protein structure graphs and residual graph attention networks. Molecules 2022 27 16 5114 10.3390/molecules27165114 36014351
    [Google Scholar]
  25. Rouillard A.D. Gundersen G.W. Fernandez N.F. Wang Z. Monteiro C.D. McDermott M.G. Ma’ayan A. The harmonizome: A collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford) 2016 2016 baw100 10.1093/database/baw100 27374120
    [Google Scholar]
/content/journals/cbio/10.2174/0115748936325300241009051347
Loading
/content/journals/cbio/10.2174/0115748936325300241009051347
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test